Showing 3411-3420 of 18626 results for "".
Emerging Directions in Menin-Directed AML Therapy
https://reachmd.com/programs/cme/emerging-directions-in-menin-directed-aml-therapy/36184/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Real-World Ready: Practical Tips for Community Oncologists
https://reachmd.com/programs/cme/real-world-ready-practical-tips-for-community-oncologists/36572/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityEarly-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
https://reachmd.com/programs/project-oncology/early-onset-endometrial-cancer-bridging-the-gap-between-age-and-outcome/35510/Explore how a novel predictive model outperforms TNM and SEER staging in guiding early-onset endometrial cancer management and improving individualized survival predictions.Physician Spotlight: Stefan Weiss, MD
https://reachmd.com/programs/practical-dermatology/physician-spotlight-stefan-weiss-md/24017/From enhancing the diagnosis and treatment of skin diseases to identifying unmet clinical needs, artificial intelligence (AI) and big data are upending the practice of dermatology.A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
https://reachmd.com/programs/cme/a-novel-therapeutic-approach-in-myeloid-malignancies-targeting-the-neddylation-pathway/11694/Learn about emerging NEDD8-activating enzyme inhibitors in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).Dialogue with the Experts: Best Practices in NSCLC
https://reachmd.com/programs/project-oncology/dialogue-with-the-experts-best-practices-in-nsclc/9626/Lung Cancer is the leading cause of cancer death and the second most diagnosed cancer in both men and women in the US. Incidence rates vary from state to state, but are of concern in the South.1 These sobering statistics are compounded by the documented variations in non-small-cell lung cancer (NSCThe Diagnostic Challenges of Spinal Cord Lesions in MS
https://reachmd.com/programs/global-neurology-academy/diagnostic-challenges-spinal-cord-lesions-ms/9573/Dr. Jiwoh Oh reviews the importance of spinal cord MRI in multiple sclerosis diagnosis.Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/pivotal-data-in-anti-pd-1-strategies-for-her2-negative-upper-gi-cancers/37690/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingAddressing House Dust Mite Allergies in Pediatric Patients
https://reachmd.com/programs/medical-industry-feature/addressing-house-dust-mite-allergies-in-pediatric-patients/35479/While medications like antihistamines or intranasal corticosteroids are commonly used in allergic rhinitis, they may not be enough to control symptoms in some patients.1-3 Allergy immunotherapy, however, works by introducing small amounts of allergens into the body so the immune system can graduallyChronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
https://reachmd.com/programs/project-oncology/chronic-graft-versus-host-disease-care-evolving-therapeutic-strategies/36317/Chronic graft-versus-host disease (cGVHD) has been a therapeutic challenge for a long time because of its multisystem involvement and limited treatment options. But in recent years, with the emergence of CSF1R inhibition and other targeted therapies, the management of cGVHD is undergoing a significa